Fig. 1
From: Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents
Treatment of COVID-19 in children with a focus on anti-rheumatic agents: current options. The figure summarizes the available anti-rheumatic agents for the treatment of COVID-19, highlighting their potential application according to disease severity. ARDS: acute respiratory distress syndrome; IVIG: intravenous immunoglobulin.; * Not sufficient evidence on the role of hydroxychloroquine and colchicine** Indicated in patients showing seroconversion; ** coagulation disorder, dehydration, cardiac or renal dysfunction